Aspire Wealth Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.22K | Hold |
89
| – | – | ﹤0.01% | 178 |
|
|
2024
Q2 | $5.77K | Hold |
89
| – | – | ﹤0.01% | 163 |
|
|
2024
Q1 | $5.76K | Hold |
89
| – | – | ﹤0.01% | 169 |
|
|
2023
Q4 | $5.86K | Hold |
89
| – | – | ﹤0.01% | 164 |
|
|
2023
Q3 | $5.08K | Hold |
89
| – | – | ﹤0.01% | 164 |
|
|
2023
Q2 | $5.46K | Hold |
89
| – | – | ﹤0.01% | 170 |
|
|
2023
Q1 | $5.59K | Hold |
89
| – | – | ﹤0.01% | 168 |
|
|
2022
Q4 | $5.65K | Buy |
+89
| New | +$5.65K | ﹤0.01% | 168 |
|